SciClone Pharmaceuticals ... (SCLN)
NASDAQ: SCLN
· Real-Time Price · USD
11.15
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM
SciClone Pharmaceuticals Revenue Breakdown
| Period Ending | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|
| Zadaxin Revenue | 800K | 39.5M | 42.2M | 37.8M | 36.5M | 33.6M |
| Zadaxin Revenue Growth | -97.97% | -6.40% | +11.64% | +3.56% | +8.63% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C Revenue | 42.56M | 39.93M | 42.12M | 38.31M | 37.26M | 34.87M | 42.19M | 40.68M | 36.28M | 32.43M | 40.18M | 33.17M | 31.29M | 25.68M | 31.67M | 33.97M | 28.17M | 28.81M | 34.67M | 39.67M | 39.42M |
| C Revenue Growth | +6.59% | -5.21% | +9.93% | +2.84% | +6.84% | -17.34% | +3.71% | +12.10% | +11.90% | -19.29% | +21.13% | +6.01% | +21.84% | -18.91% | -6.77% | +20.58% | -2.22% | -16.90% | -12.62% | +0.65% | n/a |
| Rest Of World Including U.S. And Hong Kong Revenue | 1.96M | 2.96M | 1.94M | 2.23M | 1.73M | 1.63M | 678K | 2.2M | 1.66M | 1.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Including U.S. And Hong Kong Revenue Growth | -33.91% | +52.70% | -12.92% | +28.55% | +6.51% | +140.12% | -69.24% | +32.69% | +45.57% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.29M | 7.23M | 10.71M | 7.9M | 8.13M | 7.44M | 6.49M | 7.29M | 6.78M | 7.34M |
| Selling, General, and Administrative Revenue Growth | +14.61% | -32.49% | +35.56% | -2.82% | +9.22% | +14.74% | -11.02% | +7.57% | -7.71% | n/a |
| Research and Development Revenue | 2.83M | 2.5M | 5.56M | 3.29M | 2M | 1.47M | 3.61M | 1.04M | 5.5M | 1.09M |
| Research and Development Revenue Growth | +13.35% | -55.11% | +69.04% | +64.40% | +36.33% | -59.32% | +247.06% | -81.11% | +405.51% | n/a |
| Sales and Marketing Revenue | 15.44M | 12.77M | 14.6M | 13.32M | 14.43M | 12.35M | 14.86M | 15.08M | 12.96M | 11.06M |
| Sales and Marketing Revenue Growth | +20.92% | -12.57% | +9.61% | -7.71% | +16.84% | -16.89% | -1.42% | +16.30% | +17.25% | n/a |